Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Disease area: Interstitial lung diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Corvol, F. Flamein, R. Epaud, B. Fauroux, A. Clement (Paris, France). Dramatic improvement by macrolides in surfactant deficiency with ABCA3 mutation. Eur Respir J 2009; 34: Suppl. 53, 3141

Member's Comments

No comment yet.

Related content which might interest you: Progressive lung disease caused by ABCA3 mutation Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance Year: 2020 Bi-allelic missense ABCA3 mutations in a patient with childhood ILD who reached adulthood Source: ERJ Open Res, 5 (3) 00066-2019; 10.1183/23120541.00066-2019 Year: 2019 ABCA3 deficiency in a newborn with respiratory failure Source: International Congress 2017 – Paediatric bronchology in clinical practice Year: 2017 Oral presentation: Surfactant protein-B 121ins2 heterozygosity, reduced pulmonary function and COPD in smokers Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung Year: 2010 A new mutation of surfactant protein C gene causing severe respiratory insufficiency and pulmonary fibrosis Source: Annual Congress 2012 - Paediatric bronchology Year: 2012 A new SERPINA-1 missense mutation associated with alpha-1 antitrypsin deficiency and bronchiectasis. Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017 Familial interstitial lung disease and ABCA3 gene Gly964Asp mutation Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Combined pulmonary fibrosis and emphysema syndrome associated with ABCA3 mutations Source: Eur Respir J 2014; 43: 638-641 Year: 2013 Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and paediatric pulmonary hypertension Source: Eur Respir J, 54 (2) 1801965; 10.1183/13993003.01965-2018 Year: 2019 Interstitial lung disease in a child heterozygous for the 1549C?GAA (121ins2) mutation of surfactant protein B Source: Eur Respir J 2011; 38: 985-987 Year: 2011 Topical application of gentamicin causes a reduction of sweat ion concentration in cystic fibrosis patients carrying nonsense mutations Source: Eur Respir J 2001; 18: Suppl. 33, 9s Year: 2001 Surfactant protein C G100S mutation causes familial pulmonary fibrosis in Japanese kindred Source: Eur Respir J 2011; 38: 861-869 Year: 2011 A novel non-BRICHOS surfactant protein C mutation causing infantile interstitial lung disease is associated with reduced mature SP-C level Source: International Congress 2018 – Orphan diseases in children Year: 2018 Homozygous mutations of ARFGAP1 gene in severe sarcoidosis Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020 Lung disease caused by non-null ABCA3 mutations: long-term follow-up Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Variable phenotype associated with SP-C gene mutations: fatal case with the I73T mutation Source: Eur Respir J 2004; 24: 1072-1073 Year: 2004 Structural and clinical characterization of novel missense variants of SERPINA1 gene causing alpha-1 antitrypsin deficiency Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases Year: 2019 Role of ABCA3 in paediatric interstitial lung disease associated with surfactant protein C gene mutations Source: Annual Congress 2009 - Genetics of lung diseases Year: 2009 Pulmonary fibrosis associated with TINF2 gene mutation: is somatic reversion required? Source: Eur Respir J 2014; 44: 270-271 Year: 2014 Pulmonary fibrosis associated with TINF2 gene mutation: is somatic reversion required? Source: Eur Respir J 2014; 44: 269-270 Year: 2014